Our patients are at the center of everything that we do, which is why we are so excited to announce a new partnership with OneOncology in January of 2019. This new partnership will allow West Cancer Center to build new solutions that advance our mission to provide dedicated, clinical excellence with a focus on the latest, most innovative personalized treatment plans.

 

West Cancer Center is evolving into a new model in its next chapter as a patient-centric, physician-driven and technology-powered center with a mission to improve the lives of those living with and beyond cancer.

Building upon our 40-year legacy of innovation, West Cancer Center is affiliating with a new national partner that is solely dedicated to community cancer care. This enables West Cancer Center to retain our singular focus on making physician-driven decisions to do what is best for patients, the community and the future of adult cancer care in Memphis and the Mid-South. West Cancer Center will be working with a new national partner – OneOncology – beginning January 2019 that will allow us to continue pursuing National Cancer Institute (NCI) designation and investing resources in Academic and Research Programs both locally and nationally

“We’re excited to join the dynamic new model at OneOncology,” said Dr. Lee Schwartzberg, West Cancer Center’s executive director. “Today’s challenging and complex healthcare landscape requires that we build new solutions that advance our mission to provide dedicated, clinical excellence with a focus on the latest, most innovative personalized treatment plans. This is a natural next chapter for us and maintains patients at the center of all that we do.”

The national organization is a partnership of oncologists and leading industry experts bringing together the best of oncology, technology and finance to strengthen cancer care and mitigate challenges facing community oncology centers. West Cancer Center patients will benefit from even greater access to new treatment protocols, the latest clinical trials and cutting-edge research.

Methodist LeBonheur Healthcare (MLH) and West Cancer Center will conclude their formal partnership at the end of 2018 with each organization planning for a new model that will benefit patients in this community. Both MLH and West Cancer Center have been deeply committed to their shared goal of providing the most innovative healthcare options and building a superior, innovative, research-driven adult cancer center over the past seven years.

“We’re proud of our accomplishments together,” Schwartzberg said. “Know that our existing and future patients will continue to experience seamless access to the same level of excellent adult cancer care.”

In the new partnership, West Cancer Center will be empowered to better support the entire continuum of care, including prevention and diagnosis, research and treatment, long-term survivorship and palliative and hospice care. Through this comprehensive approach, West Cancer Center aims to always improve the patient experience and outcomes.

Schwartzberg said the new partnership will enable the nation’s best oncologists to learn from unique challenges, drive meaningful innovation and leverage the benefits for patients. West Cancer Center joins two like-minded community cancer centers — New York Cancer & Blood Specialists and Tennessee Oncology – as the three founding practices of the national organization. Together, they will have more than 225 oncology providers, more than 60 care locations and treat nearly 158,000 patients per year.